News about Biotechnology

UK Industry Body Finds Sanofi in Breach Over RSV Therapy Claims Against Pfizer

A UK pharmaceutical industry watchdog has ruled that Sanofi breached the country’s code of practice by making misleading claims about its respiratory syncytial virus (RSV) therapy in comparison with a rival product from Pfizer.

Biotechnology | 04/02/2026 | By Darshana |  169

Tenacia and Golden Age Health Partner to Commercialise Ztalmy for CDKL5 Deficiency Disorder in China

Tenacia Biopharmaceuticals has granted Golden Age Health exclusive rights to commercialise Ztalmy, the first approved therapy for CDKL5 deficiency disorder, in Mainland China.

Biotechnology | 03/02/2026 | By News Bureau |  158

Piramal Pharma Solutions Commercialises Tablet-in-Capsule Technology at Indian Manufacturing Sites

Piramal Pharma Solutions has successfully developed and commercialised a tablet-in-capsule drug delivery system in India, enabling flexible dosing, dual-release profiles and improved patient-centric oral therapies.

Biotechnology | 03/02/2026 | By News Bureau |  169

USA Biomanufacturing Investment Surges Nearly 20 Percent, Report Finds

Investment in biomanufacturing across the USA has recorded a sharp rise, with pledged capital increasing by nearly 20 percent since 2024, according to a recent industry report. The surge positions biomanufacturing as one of the fastest-growing segments within the country’s advanced manufacturing landscape.
<br />

Biotechnology | 31/01/2026 | By Darshana |  185

Defence Therapeutics Advances Precision Radiopharmaceutical Development with CNL

Defence Therapeutics Inc., a publicly traded biotechnology company focused on precision intracellular drug delivery, has announced an expansion of its long-standing collaboration with Canadian Nuclear Laboratories (CNL) to accelerate the development of its radiopharmaceutical pipeline.

Biotechnology | 30/01/2026 | By Darshana |  121

Lilly Bets Big on Precision Immunology in USD 1.93 Billion Partnership

Eli Lilly and Company has entered into a strategic collaboration with biotechnology firm Repertoire Immune Medicines in a deal valued at up to USD 1.93 billion to develop novel therapies for autoimmune diseases.

Biotechnology | 30/01/2026 | By Darshana |  151

FDA Grants Breakthrough Therapy Designation to Biogen's Litifilimab for Cutaneous Lupus

Biogen’s investigational monoclonal antibody litifilimab receives FDA Breakthrough Therapy designation, marking a major step toward targeted treatment for cutaneous lupus erythematosus.

Biotechnology | 29/01/2026 | By News Bureau |  164

GSK to Acquire RAPT Therapeutics for USD 2.2 Billion to Strengthen Food Allergy and Immunology Pipeline

GSK will acquire RAPT Therapeutics for USD 2.2 billion, adding phase IIb anti-IgE antibody ozureprubart to its pipeline, targeting long-acting protection for patients with severe food allergies.

Biotechnology | 20/01/2026 | By News Bureau |  184

Onyx Scientific Strengthens Solid Form Screening Platform Following 25-Year Milestone

Onyx Scientific, the contract development and manufacturing organisation (CDMO) division of Ipca Laboratories, has announced plans to expand its solid form and material science screening capabilities in 2026, following the celebration of its 25th anniversary at the end of 2025.

Biotechnology | 20/01/2026 | By Darshana |  209

European Commission Approves Sobi's Aspaveli for Rare Kidney Diseases C3G and IC-MPGN

The European Commission has approved Sobi’s Aspaveli for adolescents and adults with rare kidney diseases C3G and IC-MPGN, marking the first approved therapy for these conditions.

Biotechnology | 19/01/2026 | By News Bureau |  175